Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 22, 2024
Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model
Ágnes Benedict, Gábor Szabó, Kinga Marczell, et al.
Journal of Medical Economics
|
March 21, 2023
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Pharmacoeconomics
|
October 1, 2021
Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review
Thitima Kongnakorn, Grammati Sarri, Andreas Freitag, et al.
Journal of Medical Economics
|
November 13, 2024
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Plos Neglected Tropical Diseases
|
June 3, 2024
The macroeconomic impact of a dengue outbreak: Case studies from Thailand and Brazil
Kinga Marczell, Elvis García, Julie Roiz, et al.
Pharmacoeconomics
|
June 6, 2022
A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes
Ágnes Benedict, Emily R Hankosky, Kinga Marczell, et al.
Journal of Medical Economics
|
May 16, 2022
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A Deger, et al.
Vaccines
|
February 28, 2023
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
Manuela Di Fusco, Diana Mendes, Lotte Steuten, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 22, 2024
Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model
Ágnes Benedict, Gábor Szabó, Kinga Marczell, et al.
Journal of Medical Economics
|
March 21, 2023
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Pharmacoeconomics
|
October 1, 2021
Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review
Thitima Kongnakorn, Grammati Sarri, Andreas Freitag, et al.
Journal of Medical Economics
|
November 13, 2024
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Plos Neglected Tropical Diseases
|
June 3, 2024
The macroeconomic impact of a dengue outbreak: Case studies from Thailand and Brazil
Kinga Marczell, Elvis García, Julie Roiz, et al.
Pharmacoeconomics
|
June 6, 2022
A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes
Ágnes Benedict, Emily R Hankosky, Kinga Marczell, et al.
Journal of Medical Economics
|
May 16, 2022
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A Deger, et al.
Vaccines
|
February 28, 2023
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
Manuela Di Fusco, Diana Mendes, Lotte Steuten, et al.
Page
of 1